These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29926891)

  • 1. Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases.
    Long V; Liang MW; Tan SH
    Int J Dermatol; 2018 Nov; 57(11):1283-1292. PubMed ID: 29926891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
    Xie Y; Wang T; Wang L
    J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
    Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH
    Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
    Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
    Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.
    López de Cáceres CVB; Rodrigues-Fernandes CI; Rendón Henao J; Morais TML; Soares CD; de Almeida OP; Fonseca FP; Delgado-Azañero W
    J Oral Pathol Med; 2021 Jul; 50(6):530-539. PubMed ID: 34097774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroa vacciniforme-like lymphoproliferative disorder with eye involvement.
    Feng X; Li F; Zhang Y; Wang L
    Pediatr Dermatol; 2021 Sep; 38(5):1387-1388. PubMed ID: 34561883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder.
    Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L
    Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
    Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
    Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
    Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
    BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
    Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M
    Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
    Garzón E; Dávila-Rodríguez JJ
    Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Involvement Preceded the Onset of Cutaneous Lesions in Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Case Report.
    Zeng R; Du L; Wang D
    Ocul Immunol Inflamm; 2022 Feb; 30(2):320-323. PubMed ID: 33021425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.
    Liu Y; Ma C; Wang G; Wang L
    J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.
    Cohen JI; Manoli I; Dowdell K; Krogmann TA; Tamura D; Radecki P; Bu W; Turk SP; Liepshutz K; Hornung RL; Fassihi H; Sarkany RP; Bonnycastle LL; Chines PS; Swift AJ; Myers TG; Levoska MA; DiGiovanna JJ; Collins FS; Kraemer KH; Pittaluga S; Jaffe ES
    Blood; 2019 Jun; 133(26):2753-2764. PubMed ID: 31064750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
    Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
    J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection.
    Katagiri Y; Mitsuhashi Y; Kondo S; Kanazawa C; Iwatsuki K; Tsunoda T
    J Dermatol; 2003 May; 30(5):400-4. PubMed ID: 12773806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
    Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
    Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.